Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.

Rose, Angela McNicolay, NathalieSandonis Martín, VirginiaMazagatos, ClaraPetrović, GorankaNiessen, F AnnabelMachado, AusendaLaunay, OdileDenayer, SarahSeyler, LucieBaruch, JoaquinBurgui, CristinaLoghin, Isabela IDomegan, LisaVaikutytė, RobertaHusa, PetrPanagiotakopoulos, GeorgeAouali, NasseraDürrwald, RalfHoward, JenniferPozo, FranciscoSastre-Palou, BartoloméNonković, DianaKnol, Mirjam JKislaya, IrinaLuong Nguyen, Liem BinhBossuyt, NathalieDemuyser, ThomasDžiugytė, AušraMartínez-Baz, IvánPopescu, CorneliuDuffy, RóisínKuliešė, MonikaSoučková, LenkaMichelaki, StellaSimon, MarcReiche, JanineOtero-Barrós, María TeresaLovrić Makarić, ZvjezdanaBruijning-Verhagen, Patricia CjlGomez, VerónicaLesieur, ZinebBarbezange, CyrilVan Nedervelde, ElsBorg, Maria-LouiseCastilla, JesúsLazar, MihaelaO'Donnell, JoanJonikaitė, IndrėDemlová, ReginaAmerali, MarinaWirtz, GilTolksdorf, KristinValenciano, MartaBacci, SabrinaKissling, Esther2023-12-062023-12-063799766610.2807/1560-7917.ES.2023.28.47.2300186http://hdl.handle.net/10029/627085enAlphaDeltaEuropeSARS-CoV-2hospitalvaccine effectivenessVaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.Article1560-7917Euro Surveill 2023; 28(47):pii.2300186